Group One Trading’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,522
Closed -$99K 8546
2026
Q1
$72.3K Buy
+1,522
New +$68.2K ﹤0.01% 4990
2025
Q4
Sell
-252
Closed -$7.86K 9192
2025
Q3
$7.09K Sell
252
-29
-10% -$878 ﹤0.01% 7373
2025
Q2
$10.3K Buy
+281
New +$9.71K ﹤0.01% 6696
2025
Q1
Sell
-682
Closed -$30.7K 8393
2024
Q4
$31.7K Buy
+682
New +$30.8K ﹤0.01% 5399
2024
Q2
Sell
-5,404
Closed -$220K 7519
2024
Q1
$185K Buy
5,404
+2,048
+61% +$73.9K ﹤0.01% 3622
2023
Q4
$124K Buy
3,356
+2,700
+412% +$62.4K ﹤0.01% 4279
2023
Q3
$13.3K Sell
656
-3,106
-83% -$68.2K ﹤0.01% 6170
2023
Q2
$77K Buy
+3,762
New +$56.4K ﹤0.01% 4882
2020
Q4
Sell
-580
Closed -$64.3K 7019
2020
Q3
$44K Buy
+580
New +$36.1K ﹤0.01% 4719

Other funds holding TWST

Group One Trading's TWST Position: Q2 2026 in Review

Group One Trading sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 1,522 shares — an estimated $99K sold.

Group One Trading first reported a position in TWST in Q3 2020 and held it in 9 quarters. The position peaked at $185K in Q1 2024. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Group One Trading reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 1,522 Twist Bioscience shares in Q2 2026, an estimated $99K.
  • Group One Trading first reported a position in Twist Bioscience in Q3 2020 and held it in 9 quarters.
  • Group One Trading's Twist Bioscience position peaked at $185K in Q1 2024.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.